TNXP
Tonix Pharmaceuticals Holding Corp
8.90$
-3.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +141.3% | +54.1% | +18.6% | +111.8% | +347.2% | +28.0% | -66.0% | -22.9% | -51.9% | +3.8% | +85.2% | +2,406.0% | +242.5% | -20.3% | -43.7% | |
| – | – | – | +211.4% | +98.6% | +98.5% | +79.8% | +42.1% | -25.6% | -45.2% | -9.1% | -10.4% | +97.4% | +174.7% | +38.2% | -15.0% | -48.5% | +25.9% | |
| – | – | – | – | +368.8% | -13.4% | +74.7% | +42.1% | -22.6% | -47.3% | -9.1% | -10.4% | +190.7% | +157.3% | +0.1% | – | – | – | |
| – | – | +9,639.5% | +14.5% | -20.2% | +118.3% | +79.4% | -6.5% | -312.9% | – | +223.7% | +3.4% | -623.5% | – | -100.0% | – | – | +48.0% | |
| – | – | – | -91.9% | +1,190.6% | -58.0% | +2,026.7% | -25.4% | -72.3% | -92.4% | +20.0% | +183.3% | +50,276.5% | +312.3% | +36.4% | -83.6% | -98.5% | +2,707.5% | |
| – | – | – | – | -11,942.1% | -58.1% | +2,513.3% | +6,066.1% | – | -56.8% | -100.1% | +183.3% | +50,276.5% | +312.3% | +36.4% | -39.6% | -99.6% | +3,673.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -24.2% | -81.8% | – | – | – | – | – | |
| – | – | – | – | +1,032.8% | +44.8% | +432.7% | -10.8% | -99.6% | -55.7% | +31,709.5% | -45.1% | -89.5% | +120.6% | -1,675.0% | -70.4% | -100.0% | – | |
| – | – | – | – | -72.0% | -50.0% | -200.0% | – | – | – | – | – | – | – | – | – | -126.3% | +310.6% | |
| – | – | – | +87.7% | +186.8% | +99.5% | +256.0% | -10.4% | -57.0% | -9.7% | +27.1% | -45.1% | +852.9% | +72.6% | -58.7% | -58.4% | +269.3% | +59.1% | |
| – | -205.4% | – | -137.7% | – | +267.9% | +367.2% | -163.4% | – | – | -106.9% | – | – | +54.0% | -157.5% | – | – | +49.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.